Geron surges after winning first US FDA approval for blood disorder drug
Go back to Geron surges after winning first US FDA approval for blood disorder drug| Geron Corp (NASDAQ: GERN) | Delayed: 1.35 +0.01 (0.75%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.34 | 52 Week High | $5.30 | |||
| Open | $1.32 | 52 Week Low | $1.81 | |||
| Day High | $1.36 | P/E | N/A | |||
| Day Low | $1.29 | EPS | $-0.35 | |||
| Volume | 13,076,814 | |||||
